Role of Oxidative Stress in the Epstein–Barr Virus Lifecycle and Tumorigenicity

References

• Chen CJ , YouSL , HsuWLet al. Epidemiology of virus infection and human cancer. Recent Results Cancer Res.217, 13–45 (2021).
   PubMedGoogle Scholar
• Wen KW , WangL , MenkeJR , DamaniaB. Cancers associated with human gammaherpesviruses. FEBS J.289(24), 7631–7669 (2022).
   PubMed Web of Science ®Google Scholar
• Bray F , FerlayJ , SoerjomataramI , SiegelRL , TorreLA , JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
   PubMed Web of Science ®Google Scholar
• Farrell PJ . Epstein–Barr virus and cancer. Annu. Rev. Pathol.14, 29–53 (2019).
   PubMed Web of Science ®Google Scholar
• Lupo J , TruffotA , AndreaniJet al. Virological markers in Epstein–Barr virus-associated diseases. Viruses15(3), 656 (2023).
   PubMed Web of Science ®Google Scholar
• Cruz-Muñoz ME , Fuentes-PananáEM. Beta and gamma human herpesviruses: agonistic and antagonistic interactions with the host immune system. Front. Microbiol.8, 2521 (2017).
   PubMed Web of Science ®Google Scholar
• Li H , LiuS , HuJet al. Epstein–Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis. Int. J. Biol. Sci.12(11), 1309–1318 (2016).
   PubMed Web of Science ®Google Scholar
• Moloney JN , CotterTG. ROS signalling in the biology of cancer. Semin. Cell Dev. Biol.80, 50–64 (2018).
   PubMed Web of Science ®Google Scholar
• Sausen DG , BhuttaMS , GalloES , DahariH , BorensteinR. Stress-induced Epstein–Barr virus reactivation. Biomolecules11(9), 1380 (2021).
   PubMed Web of Science ®Google Scholar
• Morales-Sánchez A , Fuentes-PananaEM. The immunomodulatory capacity of an Epstein–Barr virus abortive lytic cycle: potential contribution to viral tumorigenesis. Cancers (Basel)10(4), 98 (2018).
   PubMed Web of Science ®Google Scholar
• Arvey A , TemperaI , TsaiKet al. An atlas of the Epstein–Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host Microbe12(2), 233–245 (2012).
   PubMed Web of Science ®Google Scholar
• Mckenzie J , El-GuindyA. Epstein–Barr virus lytic cycle reactivation. Curr. Top. Microbiol. Immunol.391, 237–261 (2015).
   PubMed Web of Science ®Google Scholar
• Hadinoto V , ShapiroM , SunCC , Thorley-LawsonDA. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog.5(7), e1000496 (2009).
   PubMed Web of Science ®Google Scholar
• Miller G , El-GuindyA , CountrymanJ , YeJ , GradovilleL. Lytic cycle switches of oncogenic human gammaherpesviruses. Adv. Cancer Res.97, 81–109 (2007).
   PubMed Web of Science ®Google Scholar
• Schaeffner M , Mrozek-GorskaP , BuschleAet al. BZLF1 interacts with chromatin remodelers promoting escape from latent infections with EBV. Life Sci Alliance2(2), e201800108 (2019).
   PubMed Web of Science ®Google Scholar
• Long X , YangZ , LiY , SunQ , LiX , KuangE. BRLF1-dependent viral and cellular transcriptomes and transcriptional regulation during EBV primary infection in B lymphoma cells. Genomics113(4), 2591–2604 (2021).
   PubMed Web of Science ®Google Scholar
• Gorrini C , HarrisIS , MakTW. Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov.12(12), 931–947 (2013).
   PubMed Web of Science ®Google Scholar
• Galadari S , RahmanA , PallichankandyS , ThayyullathilF. Reactive oxygen species and cancer paradox: to promote or to suppress?Free Radic. Biol. Med.104, 144–164 (2017).
   PubMed Web of Science ®Google Scholar
• Tu W , WangH , LiS , LiuQ , ShaH. The anti-inflammatory and anti-oxidant mechanisms of the Keap1/Nrf2/ARE signaling pathway in chronic diseases. Aging Dis.10(3), 637–651 (2019).
   PubMed Web of Science ®Google Scholar
• Ahmed SM , LuoL , NamaniA , WangXJ , TangX. Nrf2 signaling pathway: pivotal roles in inflammation. Biochim. Biophys. Acta, Mol. Basis Dis.1863(2), 585–597 (2017).
   PubMed Web of Science ®Google Scholar
• Tonelli C , ChioIIC , TuvesonDA. Transcriptional regulation by Nrf2. Antioxid. Redox Signal.29(17), 1727–1745 (2018).
   PubMed Web of Science ®Google Scholar
• Ramezani A , NahadMP , FaghihlooE. The role of Nrf2 transcription factor in viral infection. J. Cell. Biochem.119(8), 6366–6382 (2018).
   PubMed Web of Science ®Google Scholar
• Wang L , HowellMEA , McPeakBet al. LIMD1 is induced by and required for LMP1 signaling, and protects EBV-transformed cells from DNA damage-induced cell death. Oncotarget9(5), 6282–6297 (2018).
   PubMedGoogle Scholar
• Wang L , HowellMEA , Sparks-WallaceAet al. p62-mediated selective autophagy endows virus-transformed cells with insusceptibility to DNA damage under oxidative stress. PLoS Pathog.15(4), e1007541 (2019).
   PubMed Web of Science ®Google Scholar
• Yun SM , KimYS , HurDY. LMP1 and 2A induce the expression of Nrf2 through Akt signaling pathway in Epstein–Barr virus-transformed B cells. Transl. Oncol.12(5), 775–783 (2019).
   PubMed Web of Science ®Google Scholar
• Cao JY , MansouriS , FrappierL. Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein–Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses. J. Virol.86(1), 382–394 (2012).
   PubMed Web of Science ®Google Scholar
• Wang J , NagyN , MasucciMG. The Epstein–Barr virus nuclear antigen-1 upregulates the cellular antioxidant defense to enable B-cell growth transformation and immortalization. Oncogene39(3), 603–616 (2020).
   PubMed Web of Science ®Google Scholar
• Krishna G , PillaiVS , GopiP , NairAS , VeettilMV. Epstein–Barr virus infection controls the concentration of the intracellular antioxidant glutathione by upregulation of the glutamate transporter EAAT3 in tumor cells. Virus Genes59(1), 55–66 (2023).
   PubMed Web of Science ®Google Scholar
• Ma X , YangL , XiaoLet al. Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-κB regulated ATM expression. PLOS ONE6(11), e24647 (2011).
   PubMed Web of Science ®Google Scholar
• Gilardini Montani MS , SantarelliR , FalcinelliLet al. EBV up-regulates PD-L1 on the surface of primary monocytes by increasing ROS and activating TLR signaling and STAT3. J. Leukoc. Biol.104(4), 821–832 (2018).
   PubMed Web of Science ®Google Scholar
• Nash A , RyanEJ. The oncogenic gamma herpesviruses Epstein–Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) hijack retinoic acid-inducible gene I (RIG-I) facilitating both viral and tumour immune evasion. Tumour Virus Res.14, DOI:10.1016/j.tvr.2022.200246 (2022).
   PubMedGoogle Scholar
• Rehwinkel J , GackMU. RIG-I-like receptors: their regulation and roles in RNA sensing. Nat. Rev. Immunol.20(9), 537–551 (2020).
   PubMed Web of Science ®Google Scholar
• Rosemarie Q , SugdenB. Epstein–Barr virus: how its lytic phase contributes to oncogenesis. Microorganisms8(11), 1824 (2020).
   PubMed Web of Science ®Google Scholar
• Fitzsimmons L , CartlidgeR , ChangCet al. EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins. Cell Death Differ.27(5), 1554–1568 (2020).
   PubMed Web of Science ®Google Scholar
• Jones RJ , SeamanWT , FengWHet al. Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease. Int. J. Cancer121(6), 1274–1281 (2007).
   PubMed Web of Science ®Google Scholar
• Hsu M , WuSY , ChangSSet al. Epstein–Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells. J. Virol.82(7), 3679–3688 (2008).
   PubMed Web of Science ®Google Scholar
• Feng J , ChenQ , ZhangPet al. Latent membrane protein 1 promotes tumorigenesis through upregulation of PGC1β signaling pathway. Stem Cell Rev. Rep.17(4), 1486–1499 (2021).
   PubMed Web of Science ®Google Scholar
• Shumilov A , TsaiMH , SchlosserYTet al. Epstein–Barr virus particles induce centrosome amplification and chromosomal instability. Nat. Commun.8, DOI:10.1038/ncomms14257 (2017).
   PubMed Web of Science ®Google Scholar
• Wu CC , FangCY , HuangSY , ChiuSH , LeeCH , ChenJY. Perspective: contribution of Epstein–Barr virus (EBV) reactivation to the carcinogenicity of nasopharyngeal cancer cells. Cancers (Basel)10(4), 120 (2018).
   PubMed Web of Science ®Google Scholar
• Levine B , KroemerG. Autophagy in the pathogenesis of disease. Cell132(1), 27–42 (2008).
   PubMed Web of Science ®Google Scholar
• Levine B , MizushimaN , VirginHW. Autophagy in immunity and inflammation. Nature469(7330), 323–335 (2011).
   PubMed Web of Science ®Google Scholar
• Thorburn A . Autophagy and disease. J. Biol. Chem.293(15), 5425–5430 (2018).
   PubMed Web of Science ®Google Scholar
• Cirone M . EBV and KSHV infection dysregulates autophagy to optimize viral replication, prevent immune recognition and promote tumorigenesis. Viruses10(11), 599 (2018).
   PubMed Web of Science ®Google Scholar
• Gargouri B , Van PeltJ , ElFeki Ael F , AttiaH , LassouedS. Induction of Epstein–Barr virus (EBV) lytic cycle in vitro causes oxidative stress in lymphoblastoid B cell lines. Mol. Cell. Biochem.324(1–2), 55–63 (2009).
   PubMed Web of Science ®Google Scholar
• Torii Y , KawadaJI , MurataT , YoshiyamaH , KimuraH , ItoY. Epstein–Barr virus infection-induced inflammasome activation in human monocytes. PLOS ONE12(4), e0175053 (2017).
   PubMed Web of Science ®Google Scholar
• Farina A , PeruzziG , LacconiVet al. Epstein–Barr virus lytic infection promotes activation of toll-like receptor 8 innate immune response in systemic sclerosis monocytes. Arthritis Res. Ther.19(1), 39 (2017).
   PubMedGoogle Scholar
• Galluzzi L , Bravo-SanPedro JM , KroemerG. Defective autophagy initiates malignant transformation. Mol. Cell62(4), 473–474 (2016).
   PubMed Web of Science ®Google Scholar
• Granato M , SantarelliR , FarinaAet al. Epstein–Barr virus blocks the autophagic flux and appropriates the autophagic machinery to enhance viral replication. J. Virol.88(21), 12715–12726 (2014).
   PubMed Web of Science ®Google Scholar
• Gutowski M , KowalczykS. A study of free radical chemistry: their role and pathophysiological significance. Acta Biochim. Pol.60(1), 1–16 (2013).
   PubMed Web of Science ®Google Scholar
• Lassoued S , BenAmeur R , AyadiW , GargouriB , BenMansour R , AttiaH. Epstein–Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines. Mol. Cell. Biochem.313(1–2), 179–186 (2008).
   PubMed Web of Science ®Google Scholar
• Cerimele F , BattleT , LynchRet al. Reactive oxygen signaling and MAPK activation distinguish Epstein–Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. Proc. Natl Acad. Sci. U. S. A.102(1), 175–179 (2005).
   PubMed Web of Science ®Google Scholar
• Valavanidis A , VlachogianniT , FiotakisC. 8-hydroxy-2′-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J. Environ. Sci. Health Pt. C-Environ. Carcinog. Ecotoxicol. Rev.27(2), 120–139 (2009).
   PubMed Web of Science ®Google Scholar
• Hu J , LiY , LiHet al. Targeting Epstein–Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy. Theranostics10(26), 11921–11937 (2020).
   PubMed Web of Science ®Google Scholar
• Kieser A , SterzKR. The latent membrane protein 1 (LMP1). Curr. Top. Microbiol. Immunol.391, 119–149 (2015).
   PubMed Web of Science ®Google Scholar
• Xiao L , HuZY , DongXet al. Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy. Oncogene33(37), 4568–4578 (2014).
   PubMed Web of Science ®Google Scholar
• Wang L , NingS. New look of EBV LMP1 signaling landscape. Cancers (Basel)13(21), 5451 (2021).
   PubMed Web of Science ®Google Scholar
• Marchi S , PatergnaniS , MissiroliSet al. Mitochondrial and endoplasmic reticulum calcium homeostasis and cell death. Cell Calcium69, 62–72 (2018).
   PubMed Web of Science ®Google Scholar
• Ochoa CD , WuRF , TeradaLS. ROS signaling and ER stress in cardiovascular disease. Mol. Asp. Med.63, 18–29 (2018).
   PubMed Web of Science ®Google Scholar
• Hetz C , ChevetE , OakesSA. Proteostasis control by the unfolded protein response. Nat. Cell Biol.17(7), 829–838 (2015).
   PubMed Web of Science ®Google Scholar
• He J , LiuL , TangFet al. Paradoxical effects of DNA tumor virus oncogenes on epithelium-derived tumor cell fate during tumor progression and chemotherapy response. Signal Transduct. Target. Ther.6(1), 408 (2021).
   PubMed Web of Science ®Google Scholar
• Yiu CY , ChiuYJ , LinTP. The ethyl acetate subfraction of polygonum cuspidatum root containing emodin affect EBV gene expression and Induce EBV-positive cells apoptosis. Biol. Pharm. Bull.44(12), 1837–1842 (2021).
   PubMed Web of Science ®Google Scholar
• Sun J , HuC , ZhuYet al. LMP1 increases expression of NADPH oxidase (NOX) and its regulatory subunit p22 in NP69 nasopharyngeal cells and makes them sensitive to a treatment by a NOX inhibitor. PLOS ONE10(8), e0134896 (2015).
   PubMed Web of Science ®Google Scholar
• Kawanishi S , OhnishiS , MaN , HirakuY , OikawaS , MurataM. Nitrative and oxidative DNA damage in infection-related carcinogenesis in relation to cancer stem cells. Gene Environ.38, 26 (2016).
   PubMedGoogle Scholar
• Soldan SS , AndersonEM , FraseDMet al. EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein–Barr virus-associated gastric cancer. Gastric Cancer24(5), 1076–1088 (2021).
   PubMed Web of Science ®Google Scholar
• Gruhne B , SompallaeR , MarescottiD , KamranvarSA , GastaldelloS , MasucciMG. The Epstein–Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc. Natl Acad. Sci. U. S. A.106(7), 2313–2318 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang L , LiaoY , TangL. MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer. J. Exp. Clin. Cancer Res.38(1), 53 (2019).
   PubMed Web of Science ®Google Scholar
• Iwakiri D . Multifunctional non-coding Epstein–Barr virus encoded RNAs (EBERs) contribute to viral pathogenesis. Virus Res.212, 30–38 (2016).
   PubMed Web of Science ®Google Scholar
• Kitagawa N , GotoM , KurozumiKet al. Epstein–Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J.19(24), 6742–6750 (2000).
   PubMed Web of Science ®Google Scholar
• Chávez MD , TseHM. Targeting mitochondrial-derived reactive oxygen species in T cell-mediated autoimmune diseases. Front. Immunol.12, DOI:10.3389/fimmu.2021.703972 (2021).
   Web of Science ®Google Scholar
• Ali A , OhashiM , CascoAet al. Rta is the principal activator of Epstein–Barr virus epithelial lytic transcription. PLOS Pathog.18(9), e1010886 (2022).
   PubMed Web of Science ®Google Scholar
• Godfrey A , OsbornK , SinclairAJ. Interaction sites of the Epstein–Barr virus Zta transcription factor with the host genome in epithelial cells. Access Microbiol.3(11), DOI:10.1099/acmi.0.000282 (2021).
   PubMedGoogle Scholar
• Tornesello ML , AnnunziataC , TorneselloAL , BuonaguroL , BuonaguroFM. Human oncoviruses and p53 tumor suppressor pathway deregulation at the origin of human cancers. Cancers (Basel)10(7), 213 (2018).
   PubMed Web of Science ®Google Scholar
• Huang SY , FangCY , TsaiCHet al. N-methyl-N'-nitro-N-nitrosoguanidine induces and cooperates with 12-O-tetradecanoylphorbol-1,3-acetate/sodium butyrate to enhance Epstein–Barr virus reactivation and genome instability in nasopharyngeal carcinoma cells. Chem. Biol. Interact.188(3), 623–634 (2010).
   PubMed Web of Science ®Google Scholar
• Li R , WangL , LiaoGet al. SUMO binding by the Epstein–Barr virus protein kinase BGLF4 is crucial for BGLF4 function. J. Virol.86(10), 5412–5421 (2012).
   PubMed Web of Science ®Google Scholar
• Li R , ZhuJ , XieZet al. Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe10(4), 390–400 (2011).
   PubMed Web of Science ®Google Scholar
• Hagemeier SR , BarlowEA , MengQ , KenneySC. The cellular ataxia telangiectasia-mutated kinase promotes Epstein–Barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli. J. Virol.86(24), 13360–13370 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang H , WongJP , NiG , CanoP , DittmerDP , DamaniaB. Mitochondrial protein, TBRG4, modulates KSHV and EBV reactivation from latency. PLOS Pathog.18(11), e1010990 (2022).
   PubMed Web of Science ®Google Scholar
• Hong SW , NohMH , KimYSet al. APX-115A, a pan-NADPH oxidase inhibitor, induces caspase-dependent cell death by suppressing NOX4-ROS signaling in EBV-infected retinal epithelial cells. Curr. Eye Res.45(9), 1136–1143 (2020).
   PubMed Web of Science ®Google Scholar
• Moore A , BeidlerJ , HongMY. Resveratrol and depression in animal models: a systematic review of the biological mechanisms. Molecules23(9), 2197 (2018).
   PubMed Web of Science ®Google Scholar
• Pannu N , BhatnagarA. Resveratrol: from enhanced biosynthesis and bioavailability to multitargeting chronic diseases. Biomed. Pharmacother.109, 2237–2251 (2019).
   PubMed Web of Science ®Google Scholar
• De Leo A , ArenaG , LacannaE , OlivieroG , ColavitaF , MattiaE. Resveratrol inhibits Epstein Barr virus lytic cycle in Burkitt's lymphoma cells by affecting multiple molecular targets. Antiviral Res.96(2), 196–202 (2012).
   PubMed Web of Science ®Google Scholar